Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy

Journal of Obstetrics and Gynaecology

Volumn 23, Issue 6, 2003, Pages 660-663

  Imai, A ^a   Sugiyama, M ^a   Furui, T ^a   Takahashi, S ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN ACETATE; GONADORELIN AGONIST; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; ARTICLE; BLOOD LEVEL; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; FIBRINOLYSIS; HUMAN; INTRAOPERATIVE PERIOD; MYOMECTOMY; PERITONEAL FLUID; PERITONEUM; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; SCORING SYSTEM; SECOND LOOK SURGERY; UTERUS SYNECHIA;

ADHESIONS; ADULT; BUSERELIN; FEMALE; HUMANS; INFERTILITY, FEMALE; PERITONEAL DISEASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROSPECTIVE STUDIES; SECOND-LOOK SURGERY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0344394937     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610310001604493     Document Type: Article

References (21)

1. Bakkum E., Trimbos J. and Trimbos-Kemper G. (1996) Postsurgical adhesion formation and prevention; recent developments. Reproductive Medicine Review, 5, 1-13.
2. Blithe D. (2001) Applications for GnRH antagonists. Trends in Endocrinology and Metabolism, 12, 238-240.
3. Cassel B., Nordengren J., Gustavsson B., Nilbert M. and Lund L. (1995) Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor. Journal of Clinical Endrocrinology and Metabolism, 80, 2776-2784.
4. Diamond M. and The Seprafilm Adhesion Study Group. (1996) Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomised, multicenter clinical study. Fertility and Sterility, 66, 904-910.
5. Edelstam G., Lecander I., Larsson B. and Astedt B. (1998) Fibrinolysis in the peritoneal fluid during adhesions, endometriosis and ongoing pelvic inflammatory disease. Inflammation, 22, 341-351.
6. Ellis H., Moran B., Thompson J., Parker M., Wilson M., Menzies D., McGuire A., Lower A., Hawthorn R., O'Brien F., Buchan S. and Crowe A. (1999) Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet, 353, 1476-1480.
7. Felberbaum R., Ludwig M. and Diedrich K. (2000) Clinical application of GnRh-antagonists. Molecular and Cellular Endocrinology, 166, 9-14.
8. Grow D., Coddington C., Hsiu J., Mikich Y. and Hodgen G. (1996) Role of hypoestrogenism or sex steroid antagonism in adhesion formation after myometrial surgery in primates. Fertility and Sterility, 66, 140-147.
9. Hellebrekers B., Trimbos-Kemper T., Trimbos J., Emeis J. and Kooistra T. (2000) Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertility and Sterility, 74, 203-212.
10. Holmdahl L., Eriksson E., Al-Jabreen M. and Risberg B. (1996) Fibrinolysis in human peritoneum during operation. Surgery, 119, 701-705.
11. Imai A. and Tamaya T. (2000) GnRH receptor and apoptotic signalling. Vitamins and Hormones, 59, 1-33.
12. Ince A., Eroglu A., Tarhan O. and Bulbul M. (2002) Peritoneal fibrinolytic activity in peritonitis. American Journal of Surgery, 183, 67-69.
13. Kuraoka S., Campeau J., Rodgers K., Nakamura R. and diZerega G. (1992) Effects of interleukin-1 (IL-1) on postsurgical macrophage secretion of protease and protease inhibitor activities. Journal of Surgical Research, 52, 71-78.
14. Monk B., Berman M. and Montz F. (1994) Adhesions after extensive gynecologic surgery; clinical significance, etiology and prevention. American Journal of Obstetrics and Gynecology, 170, 1396-1403.
15. O'Leary D. and Coakley J. (1992) The influence of suturing and sepsis on the development of postoperative peritoneal adhesions. Annals of the Royal College for Surgery England, 74, 134-137.
16. Risberg B. (1997) Adhesions: preventive strategies. European Journal of Surgery, 577, 32-39.
17. Sharpe-Timms K., Zimmer R., Jolliff W., Wright J., Nothnick W. and Curry T. (1998) Gonadotrophin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertility and Sterility, 69, 916-923.
18. The Myomectomy Adhesion Multicenter Study Group. (1995) An expanded polytetrafluoroethylene barrier (Gore-Tex surgical membrane) reduced post-myomectomy adhesion formation. Fertility and Sterility, 63, 491-493.
19. Tulandi T., Murray C. and Guralnick M. (1993) Adhesion formation and reproductive outcome after myomectomy and second-look laparoscopy. Obstetrics and Gynecology, 82, 213-215.
20. Winkler U., Buhler K., Koslowski S., Oberhoff C. and Schindler A. (1992) Plasmatic haemostasis in gonadotrophin-releasing hormone analogue therapy: effects of leuprorelin acetate depot on coagulatory and fibrinolytic activities. Clinical Therapy, 14A, 114-120.
21. Wright J. and Sharpe-Timms K. (1995) Gonadotrophin-releasing hormone agonist therapy reduces postoperative adhesion formation and reformation after adhesiolysis in rat models for adhesion formation and endometriosis. Fertility and Sterility, 63, 1094-1100.